The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
Clinical trial NCT03292861 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03292861
- Sponsor
- Cedars-Sinai Medical Center
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2026-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.